Video Experimental Relacionado
Updated: Jun 14, 2026
06:03
Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
Published on: May 23, 2015
22.4K
Un ensayo aleatorizado de navegación del paciente con monitoreo de síntomas en cáncer de pulmón avanzado
Kumar Prabhash1, Vanita Noronha1, Vijay Patil2
1Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
European journal of cancer (Oxford, England : 1990)
|August 24, 2025
Resumen
La navegación del paciente con el monitoreo de los síntomas acelera significativamente el inicio del tratamiento y mejora el cumplimiento en pacientes con cáncer de pulmón avanzado. Este enfoque reduce las visitas de emergencia pero no afecta la calidad de vida o los resultados de supervivencia.
Área de la Ciencia:
- En el campo de la oncología
- Ensayos clínicos
- Gestión de la atención al paciente
Sus antecedentes:
- Las barreras en la atención del cáncer requieren intervenciones de apoyo.
- Los navegantes pacientes pueden mitigar estas barreras.
- El papel de la monitorización de los síntomas en el tratamiento del cáncer de pulmón avanzado necesita ser evaluado.
Objetivo del estudio:
- Evaluar el impacto de la navegación del paciente combinada con el monitoreo de los síntomas.
- Evaluar los efectos sobre la calidad de vida y la prestación de cuidados en pacientes con cáncer de pulmón avanzado.
- Analizar los parámetros secundarios, incluidos el inicio del tratamiento, el cumplimiento y la supervivencia.
Principales métodos:
- Ensayos controlados aleatorios en los que participaron 150 pacientes adultos con cáncer de pulmón avanzado.
- El grupo de intervención recibió orientación del paciente (coordinación, programación, seguimiento de los síntomas).
- Efectos primarios: cambio en la calidad de vida a las 12 semanas; efectos secundarios: tiempo hasta el tratamiento, visitas no planificadas, cumplimiento, supervivencia.
Principales resultados:
- El grupo de intervención mostró un tiempo de inicio del tratamiento significativamente más corto (19 frente a 28 días).
- Frecuencia reducida de visitas de emergencia/ no planificadas (67% frente a 88%) y mayor cumplimiento del tratamiento (85% frente a 68%) en el brazo de intervención.
- No se observaron diferencias significativas en la calidad de vida, el estado de rendimiento, la supervivencia libre de progresión (SFP) o la supervivencia global (SO).
Conclusiones:
- La navegación del paciente con el monitoreo de los síntomas mejora la atención del cáncer.
- Acelera el inicio del tratamiento, mejora el cumplimiento y disminuye la utilización no planificada de la atención médica.
- La intervención no afecta negativamente la calidad de vida o la supervivencia del paciente.
Palabras clave:
Países en desarrolloAcceso a los servicios de saludLas neoplasias pulmonaresCuidados paliativosNavegación del pacienteCalidad de vidaEvaluación de los síntomasMás Videos Relacionados
Videos de Conceptos Relacionados
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...